Activity of Fulvestrant 500 mg Versus Anastrozole 1 mg As First-Line Treatment for Advanced Breast Cancer: Results From the FIRST StudyJ.F.R. Robertson, Matthew J. Ellis, Justin P.O. Lindemann et al.|Journal of Clinical Oncology|2009Cited by 312